Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
North Atlantic Seed Co is a prominent United States-based cannabis seed bank that specializes in the distribution of high-quality cannabis genetics. Based in Maine, the company serves as a major retail and wholesale hub for feminized, auto-flowering, and regular cannabis seeds sourced from elite global breeders. While the seeds are often sold as souvenir items under current legal definitions, the company provides the essential genetic material used by medical patients and researchers in the cannabis space. Their operations emphasize a curated selection of stable genetics, ensuring diversity and reliability for cultivators. By partnering with top-tier breeders, North Atlantic Seed Co facilitates the availability of specific chemotypes and cultivars relevant to therapeutic applications. The company is recognized for its efficient logistics, customer support, and commitment to the preservation of cannabis biodiversity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on North Atlantic Seed Co.